Vaccine maker Moderna forecasts lower sales next year, shares tumble 17% to near four-year low
Moderna pushed back its break-even goal by two years on Thursday as it delayed the timeline for developing several key ...
Moderna pushed back its break-even goal by two years on Thursday as it delayed the timeline for developing several key ...
British drugmaker GSK said on Thursday it plans to sell about 385 million shares, representing its entire shareholding, in spun-off ...
© 2024 LSD News title="Jegtheme">Jegtheme.